QSAM Biosciences Other Current Liabilities

QSAM Biosciences posts a other current liabilities of $460K as of December 2023. That compares with $380K in the prior-year period — up 18.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, QSAM Biosciences's other current liabilities was $380K. The latest reading is $460K — a 18.7% year-over-year increase (period ending December 2023). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of QSAM Biosciences's financial statement story. At $460K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for QSAM's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; QSAM Biosciences's other metric pages and overview cover the third.

Judging QSAM Biosciences against Materials peers is usually better than using a market-wide rule of thumb. Business models inside Materials are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $460K here, then scan peer and history charts to see if the gap is persistent.